Merck & Co (MSD) has announced that it is discontinuing two Phase III Keytruda (pembrolizumab) clinical trials. The KEYNOTE-867 (NCT03924869) trial was evaluating Keytruda plus stereotactic body ...

22 September 2025 The pharma giant invalidates a university's patent while gaining FDA approval for a new subcutaneous ...

LLC) in the Philippines, a subsidiary of the global biopharmaceutical company Merck & Co., Inc., officially launched “Gen V: Your Vibe, Your Move,” a youth-driven movement designed to boost education ...

MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to ...

Product Type :Auto Part Package Dimensions :3.9" L X3.5" W X0.9" H Country Of Origin :China Package Weight :0.91Lbs Msd'S Proprietary Ceramic Formula Provides The Highest Dielectric Strength ...